Profile
Sector:
HealthcareCountry:
United StatesIPO:
10 February 2005Website:
http://www.prestigebrands.comNext earnings report:
07 February 2025Last dividends:
27 September 2018Next dividends:
N/APrice
regular market | 5 min agoDividend
Analysts recommendations
Institutional Ownership
PBH Latest News
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairman, President & Chief Executive Officer Chris Sacco - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer Susan Anderson - Canaccord Anthony Lebiedzinski - Sidoti & Co. Operator Good day, ladies and gentlemen, and welcome to Prestige Consumer Healthcare's Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.07 per share a year ago.
Prestige Consumer Healthcare (PBH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
TARRYTOWN, N.Y., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2024.
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
Prestige Consumer's (PBH) Q4 performance is negatively affected by supply chain challenges, leading to difficulties in meeting retailer demand.
While the revenue and EPS of Prestige Consumer Healthcare (PBH) provide insight into its quarterly performance ending in March 2024, it may be beneficial to also analyze how certain important metrics stack up against Wall Street predictions and figures from the previous year.
Prestige Consumer Healthcare (PBH) reported quarterly earnings of $1.02 per share, falling short of the Zacks Consensus Estimate of $1.14 per share. This is lower than the earnings of $1.07 per share reported in the same quarter last year.
- 1(current)
- 2
What type of business is Prestige Consumer Healthcare?
Prestige Consumer Healthcare Inc. is engaged in the production and distribution of over-the-counter medical products. The company has a wide range of medical products, including pain relievers, dermatological products, cold remedies, products for eye, ear, oral, gastrointestinal health, as well as products for women's health. The company's portfolio includes pain relief powders under the BC/Goody brand, Boudreaux's Butt Paste children's ointments, Chloraseptic sore throat lozenges, Clear Eyes products for reducing eye redness. In addition, the company offers wart removal products, earwax removal products, as well as enemas, stomach upset remedies, Monistat vaginal antifungal products and Nix lice and parasite treatments. The company was founded in 1996, with its headquarters located in Tarrytown, New York.
What sector is Prestige Consumer Healthcare in?
Prestige Consumer Healthcare is in the Healthcare sector
What industry is Prestige Consumer Healthcare in?
Prestige Consumer Healthcare is in the Drug Manufacturers - Specialty & Generic industry
What country is Prestige Consumer Healthcare from?
Prestige Consumer Healthcare is headquartered in United States
When did Prestige Consumer Healthcare go public?
Prestige Consumer Healthcare initial public offering (IPO) was on 10 February 2005
What is Prestige Consumer Healthcare website?
https://www.prestigebrands.com
Is Prestige Consumer Healthcare in the S&P 500?
No, Prestige Consumer Healthcare is not included in the S&P 500 index
Is Prestige Consumer Healthcare in the NASDAQ 100?
No, Prestige Consumer Healthcare is not included in the NASDAQ 100 index
Is Prestige Consumer Healthcare in the Dow Jones?
No, Prestige Consumer Healthcare is not included in the Dow Jones index
When was Prestige Consumer Healthcare the previous earnings report?
No data
When does Prestige Consumer Healthcare earnings report?
The next expected earnings date for Prestige Consumer Healthcare is 07 February 2025